NasdaqGS:OPKHealthcare
Should OPKO Health’s Royalty-Backed US$125 Million Financing Shift Matter to OPKO Health (OPK) Investors?
On 13 August 2026, OPKO Health expanded its financing relationship with HealthCare Royalty, issuing US$125,000,000 of senior secured notes maturing in 2044 and backed by royalty interests from its mazdutide license with Eli Lilly, converting future royalties into immediate non-dilutive capital.
A key feature of this structure is the 1.5-times cap on total payments funded by mazdutide-related royalties, after which OPKO retains full future royalty economics from the financed stream, balancing...